| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,465 |
642 |
$68K |
| 99305 |
|
887 |
885 |
$12K |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
474 |
443 |
$4K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
66 |
50 |
$4K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
535 |
407 |
$3K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
46 |
46 |
$2K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
47 |
37 |
$1K |
| 87428 |
|
17 |
15 |
$1K |
| 90674 |
|
55 |
29 |
$876.90 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
57 |
57 |
$740.25 |
| 99326 |
|
39 |
39 |
$592.29 |
| 90688 |
|
53 |
29 |
$518.33 |
| 99441 |
|
15 |
14 |
$505.47 |
| 99306 |
Prolong nursin fac eval 15m |
14 |
14 |
$392.35 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
48 |
45 |
$191.67 |
| 99442 |
|
12 |
12 |
$63.29 |
| 99335 |
|
13 |
13 |
$51.00 |
| G0008 |
Administration of influenza virus vaccine |
58 |
58 |
$13.23 |
| 99325 |
|
26 |
26 |
$0.00 |